We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
1126
Diversified Healthcare Trust
DHC
$2.23B
| $2.2M | 0.01% |
2,223,200
+617,500
| +38% | +$990K |
|
1127
LivaNova
LIVN
$4.51B
| $2.2M | 0.01% |
43,245
+8,800
| +26% | +$522K |
|
1128
Helios Technologies
HLIO
$2.56B
| $2.18M | 0.01% |
43,100
+31,700
| +278% | +$1.92M |
|
|
WSR
1129
DELISTED
Whitestone REIT
WSR
| $2.18M | 0.01% |
257,500
-20,400
| -7% | -$209K |
|
1130
News Corp Class A
NWSA
$15.3B
| $2.17M | 0.01% |
143,600
+18,200
| +15% | +$305K |
|
|
SEI
1131
Solaris Energy Infrastructure
SEI
$2.9B
| $2.17M | 0.01% |
231,700
-19,900
| -8% | -$205K |
|
|
EBIX
1132
DELISTED
Ebix Inc
EBIX
| $2.16M | 0.01% |
114,096
+22,800
| +25% | +$502K |
|
1133
Cactus
WHD
$3.69B
| $2.16M | 0.01% |
56,200
+15,000
| +36% | +$601K |
|
1134
Establishment Labs
ESTA
$2.7B
| $2.16M | 0.01% |
39,500
+19,000
| +93% | +$1.14M |
|
|
FBMS
1135
DELISTED
The First Bancshares, Inc.
FBMS
| $2.15M | 0.01% |
72,100
-3,800
| -5% | -$114K |
|
1136
iShares Biotechnology ETF
IBB
$9.55B
| $2.15M | 0.01% |
+18,399
| New | +$2.28M |
|
1137
Oramed Pharmaceuticals
ORMP
$171M
| $2.15M | 0.01% |
331,500
-350,300
| -51% | -$2.84M |
|
1138
Aviat Networks
AVNW
$264M
| $2.15M | 0.01% |
78,400
+23,400
| +43% | +$702K |
|
1139
First Merchants
FRME
$2.74B
| $2.14M | 0.01% |
55,347
-32,381
| -37% | -$1.28M |
|
1140
Ultragenyx Pharmaceutical
RARE
$2.56B
| $2.13M | 0.01% |
+51,400
| New | +$2.64M |
|
1141
Replimune Group
REPL
$449M
| $2.12M | 0.01% |
122,700
-12,500
| -9% | -$238K |
|
1142
Hackett Group
HCKT
$266M
| $2.12M | 0.01% |
119,500
-10,700
| -8% | -$217K |
|
1143
Westamerica Bancorp
WABC
$1.39B
| $2.12M | 0.01% |
40,500
+32,200
| +388% | +$1.84M |
|
1144
Agnico Eagle Mines
AEM
$71.9B
| $2.11M | 0.01% |
50,000
+22,200
| +80% | +$952K |
|
|
LAND
1145
Gladstone Land Corp
LAND
$366M
| $2.11M | 0.01% |
116,700
+40,800
| +54% | +$956K |
|
1146
AtriCure
ATRC
$2.01B
| $2.11M | 0.01% |
54,000
+32,300
| +149% | +$1.48M |
|
1147
Horizon Bancorp
HBNC
$1.06B
| $2.1M | 0.01% |
117,187
-11,800
| -9% | -$222K |
|
1148
Champion Homes
SKY
$4.58B
| $2.1M | 0.01% |
39,800
-32,900
| -45% | -$1.92M |
|
1149
Pliant Therapeutics
PLRX
$66.3M
| $2.1M | 0.01% |
100,600
+45,400
| +82% | +$869K |
|
1150
Employers Holdings
EIG
$912M
| $2.09M | 0.01% |
60,600
+24,800
| +69% | +$973K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.